Yili Chuanning Biotechnology Co.,Ltd.

SZSE:301301 Stock Report

Market Cap: CN¥28.5b

Yili Chuanning BiotechnologyLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xuheng Deng

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

Jul 23
If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

May 31
We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

Feb 26
Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

CEO

Xuheng Deng (37 yo)

no data

Tenure

CN¥1,389,100

Compensation

Mr. Xuheng Deng serves as GM & Director of Yili Chuanning Biotechnology Co.,Ltd.